ClinicalTrials.Veeva

Menu

Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Fuchs Endothelial Corneal Dystrophy

Treatments

Other: collection of medical data

Study type

Observational

Funder types

Other

Identifiers

NCT07117071
IRBN1392025/CHUSTE

Details and patient eligibility

About

The prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) varies from 3.7 to 21.6% of adults depending on the population studied (country and age class), the method of diagnosis and the definition adopted. In the absence of available data for France, we analyzed the prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) in a specific sub-population.

Full description

The Primary purpose is to Estimate the prevalence of Fuchs' endothelial dystrophy in the French population in dermatology population.

Enrollment

1,200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with screening of Fuchs endothelial corneal dystrophy

Exclusion criteria

  • Patients under guardianship
  • Patients unable to receive informed consent
  • Patients with anterior segment pathology (declarative) (the eye concerned will not be photographed)

Trial design

1,200 participants in 1 patient group

screening of Fuchs endothelial corneal dystrophy
Description:
Patients with screening of Fuchs endothelial corneal dystrophy will be included.
Treatment:
Other: collection of medical data

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems